Fatty Acid Diet and Prostate Cancer: a Treasure Hunt or a Wild Goose Chase?

Overview

Journal Prostate Cancer Prostatic Dis

Specialties Oncology
Urology

Date 2024 Jun 18

PMID 38890423

Authors

Georges Mjaess

Thierry Roumeguere

Keziah Korpak

Pierre Van Antwerpen

Karim Zouaoui Boudjeltia

Affiliations

Soon will be listed here.

References

Snaebjornsson M, Janaki-Raman S, Schulze A . Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab. 2019; 31(1):62-76. DOI: 10.1016/j.cmet.2019.11.010. View

Wu X, Daniels G, Lee P, Monaco M . Lipid metabolism in prostate cancer. Am J Clin Exp Urol. 2014; 2(2):111-20. PMC: 4219300. View

Siltari A, Syvala H, Lou Y, Gao Y, Murtola T . Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor's Immune Environment. Cancers (Basel). 2022; 14(17). PMC: 9454444. DOI: 10.3390/cancers14174293. View

Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L . Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021; 33(8):1701-1715.e5. DOI: 10.1016/j.cmet.2021.05.016. View

Kelavkar U, Hutzley J, Dhir R, Kim P, Allen K, McHugh K . Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia. 2006; 8(2):112-24. PMC: 1578514. DOI: 10.1593/neo.05637. View

Apte S, Cavazos D, Whelan K, DeGraffenried L . A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer. Nutr Cancer. 2013; 65(4):556-62. DOI: 10.1080/01635581.2013.775316. View

Brasky T, Darke A, Song X, Tangen C, Goodman P, Thompson I . Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013; 105(15):1132-41. PMC: 3735464. DOI: 10.1093/jnci/djt174. View

Liss M, Al-Bayati O, Gelfond J, Goros M, Ullevig S, DiGiovanni J . Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study. Prostate Cancer Prostatic Dis. 2018; 22(2):244-251. PMC: 6685438. DOI: 10.1038/s41391-018-0105-2. View

Wang L, Ho J, Glackin C, Martins-Green M . Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl Oncol. 2012; 5(5):344-55. PMC: 3470115. DOI: 10.1593/tlo.12190. View

10.

Gasmi J, Sanderson J . Growth inhibitory, antiandrogenic, and pro-apoptotic effects of punicic acid in LNCaP human prostate cancer cells. J Agric Food Chem. 2010; 58(23):12149-56. DOI: 10.1021/jf103306k. View

11.

Paller C, Ye X, Wozniak P, Gillespie B, Sieber P, Greengold R . A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer Prostatic Dis. 2012; 16(1):50-5. PMC: 3549301. DOI: 10.1038/pcan.2012.20. View

12.

Pantuck A, Pettaway C, Dreicer R, Corman J, Katz A, Ho A . A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2015; 18(3):242-8. DOI: 10.1038/pcan.2015.32. View

13.

Paller C, Pantuck A, Carducci M . A review of pomegranate in prostate cancer. Prostate Cancer Prostatic Dis. 2017; 20(3):265-270. PMC: 5555799. DOI: 10.1038/pcan.2017.19. View

14.

Scheinberg T, Mak B, Butler L, Selth L, Horvath L . Targeting lipid metabolism in metastatic prostate cancer. Ther Adv Med Oncol. 2023; 15:17588359231152839. PMC: 9893394. DOI: 10.1177/17588359231152839. View